DCN and breast cancer: MMP2 degrades type IV collagen and promotes epithelial–mesenchymal transition and metastasis.[35] This is in concordance with the results obtained in the present study, which indicated that decorin may inhibit the invasion and metastasis of BC by reducing MMP2 expression.